WHO ICTRP trial
Analysis for blood concentration and anti-drug antibody in anti-tumor antibody…
ChiCTR1800019946 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800019946 |
|---|---|
| Public title | Analysis for blood concentration and anti-drug antibody in anti-tumor antibody drugs |
| Scientific title | Analysis for blood concentration and anti-drug antibody in anti-tumor antibody drugs |
| Primary sponsor | National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Relative factors research |
| Phase | Basic Science |
| Countries | China |
| Conditions | Solid tumor |
| Interventions | Case series:None |
| Registration date | Dec 9, 2018 |
| Target size | Case series:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: